Skip to main content
. 2023 Jul 13;23:656. doi: 10.1186/s12885-023-11134-4

Fig. 3.

Fig. 3

HER2 evolution from primary breast cancer to distant metastases. a The overall rate of HER2 discordance. b HER2 discordant cases in HR-positive and triple-negative breast cancers respectively. c Evolution of the HER2 status between primary tumors and metastases stratified by molecular subtypes of primary BC (Chi-square test). d Evolution of the HER2 status between primary tumors and metastases stratified by T stages of primary BC (Fisher’s exact test). BC breast cancer, N number